1083P A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma
| Autor: | Shoushtari, A.N., Olszanski, A.J., Nyakas, M., Hornyak, T.J., Wolchok, J.D., Levitsky, V., Møller, A-S., Kuryk, L., Risberg Handeland, K., Jäderberg, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S897-S898 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|